Insider Trading March 19, 2026

CF Industries VP Disposes of $187,035 in Shares Amid Recent Earnings and Market Volatility

Erik M. Mayer sells 1,500 CF shares as analysts reprice the stock following a strong quarter and geopolitical-driven rallies

By Leila Farooq CF
CF Industries VP Disposes of $187,035 in Shares Amid Recent Earnings and Market Volatility
CF

Erik M. Mayer, vice president for Clean Energy and Business Development at CF Industries Holdings, sold 1,500 shares on March 17, 2026, realizing $187,035. The move comes after CF reported stronger-than-expected fourth-quarter adjusted EBITDA and as analysts adjust price targets and ratings in response to recent stock gains and Middle East tensions.

Key Points

  • Erik M. Mayer sold 1,500 CF Industries shares on March 17, 2026, at $124.69 per share for $187,035 and now directly owns 6,341 shares.
  • CF Industries reported Q4 adjusted EBITDA of $821 million, beating BofA Securities’ estimate of $754 million; lower natural gas prices and hedging added about $50 million.
  • Analyst actions: BofA raised its price target to $86 from $78 but kept an Underperform rating; Mizuho downgraded to Underperform from Neutral with a $100 target after substantial recent stock gains.

Erik M. Mayer, CF Industries Holdings Inc.'s vice president overseeing Clean Energy and Business Development, executed a sale of 1,500 shares of the company's common stock on March 17, 2026. The shares changed hands at $124.69 apiece, generating proceeds of $187,035. After the disposition, Mayer retains direct ownership of 6,341 CF shares.

The insider trade arrives against a backdrop of quarterly results and shifting analyst views. CF Industries reported adjusted EBITDA of $821 million for the fourth quarter, topping BofA Securities' forecast of $754 million. The firm attributed part of the outperformance to lower natural gas prices, which contributed an incremental $50 million to results, aided by the company’s hedging activities.

Following the quarterly release, BofA Securities revised its price target for CF to $86 from $78, while keeping an Underperform rating on the stock. The bank’s updated target reflects the stronger-than-expected EBITDA but does not alter its near-term view on the shares.

Separately, Mizuho moved to downgrade CF Industries from Neutral to Underperform and set a new price target of $100. Mizuho’s action came after the stock advanced roughly 24% since early March, adding to a prior 29% gain in preceding months. The firm cited the recent run-up in oil and fertilizer prices amid heightened tensions in the Middle East as a driver of those gains.

Mizuho analyst Edlain Rodriguez expressed concern that recent price appreciation may be excessive, even as the rally provided a temporary boost to earnings and the company is expected to reduce net debt by 2026.

Market trading reflected geopolitical anxieties: CF Industries' shares rose 3.2% in premarket activity alongside other fertilizer names after reports that Iranian boats attacked fuel tankers in Iraqi waters. The episode appears to have prompted short-term buying pressure on fertilizer stocks tied to regional supply and transport concerns.

Taken together, the insider sale, quarterly beat, and analyst repositioning give investors multiple data points on CF Industries’ near-term trajectory: solid quarterly performance supported by commodity and hedging dynamics, offset by analyst caution regarding recent share-price gains and geopolitical volatility that can affect energy and fertilizer markets.

Risks

  • Geopolitical developments in the Middle East have prompted volatile reactions in fertilizer and energy-related equities, as evidenced by a 3.2% premarket rise in CF following reports of attacks on fuel tankers.
  • Analyst caution and downgrades highlight the risk that recent price appreciation in CF shares may be overextended, potentially increasing downside in the event commodity prices or sentiment reverse.
  • Earnings boosts tied to temporary factors - such as lower natural gas prices and hedging gains - may not be sustained, introducing uncertainty for future EBITDA and financial metrics.

More from Insider Trading

Alignment Healthcare CHRO Disposes $425k in Shares Across Two Transactions Mar 19, 2026 CytomX SVP Sells Shares to Cover RSU Taxes as Company Advances Clinical and Financing Plans Mar 19, 2026 Silver Lake Sells $36.7M in Dell Shares as Company Reports Strong AI Server Performance Mar 19, 2026 CytomX CFO Sells $124,111 in Stock as Company Advances Clinical Programs and Launches Large Offering Mar 19, 2026 Silver Lake Entities Liquidate $36.6M in Dell Class C Stock Amid Ongoing AI Momentum Mar 19, 2026